Atlas Trials

Novel Subtypes and Treatment Strategies of Patients with Unresectable Combined Hepatocellular Cholangiocarcinoma Based on Multimodal Data

Clinical trial NCT06849180 · RECRUITING

Trial details

NCT number
NCT06849180
Sponsor
Zhongda Hospital
Status
RECRUITING
Study type
OBSERVATIONAL
Combined Hepatocellular-cholangiocarcinomaCombined Hepatocellular Carcinoma and CholangiocarcinomaCombined Hepatocellular and Cholangiocarcinoma
Start date
2024-12-31
Primary completion
2025-11-30
Enrollment
198

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.